Skip to main content
CND In the News

Dr. Levine to Present at Controversies in Movement Disorders Event

By May 16, 2022May 19th, 2022No Comments

Dr. Levine to Present at Controversies in Movement Disorders Event

Dr. Todd Levine, Chief Medical Officer and Co-Founder of CND Life Sciences will present as part of a Controversies in Movement Disorders panel discussion at 6:30 pm on May 23, 2022, in Punta Gorda, FL. The presenters will discuss the DaTscan procedure vs the Syn-One Test® in the diagnosis of Parkinson’s disease.

In addition to Dr. Levine, speakers include Dr. Thomas Fabian, Medical Director, AKUMIN, and Dr. Ramon A. Gil, Medical Director, Parkinson’s Disease Treatment Center of Southwest Florida. Two CME credits will be provided by the Charlotte County Medical Society.

The event will be held at the Charlotte Harbor Event and Conference Center at 75 Taylor Street, Punta Gorda, FL 33950 from 6:30 – 9:00 pm EST. Dinner will be served.

You can also attend virtually. Use this link to join the discussion at 7:00 pm EST.

To register, call 941-323-9554 or email

CND Life Sciences

CND Life Sciences is the creator of the Syn-One Test™, the world’s first commercially available test to visualize abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test is an objective, evidence-based diagnostic tool to aid in the diagnosis of Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, pure autonomic failure, or REM sleep behavior disorder.